Related references
Note: Only part of the references are listed.Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
David R. Beers et al.
LANCET NEUROLOGY (2019)
Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy
Jeannie Chew et al.
MOLECULAR NEURODEGENERATION (2019)
Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity
Yong-Jie Zhang et al.
SCIENCE (2019)
A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis
David Devos et al.
SCIENTIFIC REPORTS (2019)
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
Archana Prasad et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS
Andre Varcianna et al.
EBIOMEDICINE (2019)
Functional microglia neurotransmitters in amyotrophic lateral sclerosis
Cinzia Volonte et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS
Hannah Rostalski et al.
FRONTIERS IN NEUROSCIENCE (2019)
COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
Norbert Mueller
FRONTIERS IN PSYCHIATRY (2019)
C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis
Scott P. Allen et al.
BRAIN (2019)
Inflammation in ALS/FTD pathogenesis
Madelyn E. McCauley et al.
ACTA NEUROPATHOLOGICA (2019)
C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A
Thomas G. Moens et al.
ACTA NEUROPATHOLOGICA (2019)
The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis
Alessia Serrano et al.
CELLS (2019)
Repeat-associated non-AUG translation in C9orf72-ALS/FTD is driven by neuronal excitation and stress
Thomas Westergard et al.
EMBO MOLECULAR MEDICINE (2019)
Efficacy and safety of edaravone in treatment of amyotrophic lateral sclerosisa systematic review and meta-analysis
Linting Luo et al.
NEUROLOGICAL SCIENCES (2019)
Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials
Mahmoud Barbarawi et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2019)
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Principles of inflammasome priming and inhibition: Implications for psychiatric disorders
Francis J. Herman et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets
Santa Mammana et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis
Yong-Jie Zhang et al.
NATURE MEDICINE (2018)
C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2α phosphorylation
Weiwei Cheng et al.
NATURE COMMUNICATIONS (2018)
A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy
Maneka Chitiprolu et al.
NATURE COMMUNICATIONS (2018)
Characterizations of distinct parallel and antiparallel G-quadruplexes formed by two-repeat ALS and FTD related GGGGCC sequence
Bo Zhou et al.
SCIENTIFIC REPORTS (2018)
A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-re ated neurodegeneration
Daniel A. Solomon et al.
BRAIN (2018)
Repeat-associated non-ATG (RAN) translation
John Douglas Cleary et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
C9orf72 Dipeptide Repeats Cause Selective Neurodegeneration and Cell-Autonomous Excitotoxicity in Drosophila Glutamatergic Neurons
Wangchao Xu et al.
JOURNAL OF NEUROSCIENCE (2018)
C9orf72-mediated ALS and FTD: multiple pathways to disease
Rubika Balendra et al.
NATURE REVIEWS NEUROLOGY (2018)
The Kaleidoscope of Microglial Phenotypes
Marissa L. Dubbelaar et al.
FRONTIERS IN IMMUNOLOGY (2018)
C9orf72, a protein associated with amyotrophic lateral sclerosis (ALS) is a guanine nucleotide exchange factor
Shalini Iyer et al.
PEERJ (2018)
Microglia and macrophages in brain homeostasis and disease
Qingyun Li et al.
NATURE REVIEWS IMMUNOLOGY (2018)
RNA-Binding Proteins in Amyotrophic Lateral Sclerosis
Melody Zhao et al.
MOLECULES AND CELLS (2018)
C9ORF72 Regulates Stress Granule Formation and Its Deficiency Impairs Stress Granule Assembly, Hypersensitizing Cells to Stress
Niran Maharjan et al.
MOLECULAR NEUROBIOLOGY (2017)
Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Deepti Lall et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
NADPH oxidase in brain injury and neurodegenerative disorders
Merry W. Ma et al.
MOLECULAR NEURODEGENERATION (2017)
Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role
C. J. Garwood et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2017)
Comparison of the Neuroprotective and Anti-Inflammatory Effects of the Anthocyanin Metabolites, Protocatechuic Acid and 4-Hydroxybenzoic Acid
Aimee N. Winter et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Relationships between Stress Granules, Oxidative Stress, and Neurodegenerative Diseases
Lihua Chen et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
ALS/FTD-Associated C9ORF72 Repeat RNA Promotes Phase Transitions In Vitro and in Cells
Marta M. Fay et al.
CELL REPORTS (2017)
The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches
Maria Concetta Geloso et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD
Brian D. Freibaum et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Modeling ALS and FTD with iPSC-derived neurons
Sebum Lee et al.
BRAIN RESEARCH (2017)
The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter
I. Gijselinck et al.
MOLECULAR PSYCHIATRY (2016)
C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles
Kyung-Ha Lee et al.
CELL (2016)
Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death
Chantal Sellier et al.
EMBO JOURNAL (2016)
Structural insight into C9orf72 hexanucleotide repeat expansions: Towards new therapeutic targets in FTD-ALS
Vijay Kumar et al.
NEUROCHEMISTRY INTERNATIONAL (2016)
C9orf72 is required for proper macrophage and microglial function in mice
J. G. O'Rourke et al.
SCIENCE (2016)
Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase
Maria-Letizia Campanari et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis
Ching-Hua Lu et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72
Marka van Blitterswijk et al.
ACTA NEUROPATHOLOGICA (2015)
C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits
Max Koppers et al.
ANNALS OF NEUROLOGY (2015)
TDP-43 activates microglia through NF-κB and NLRP3 inflammasome
Weihua Zhao et al.
EXPERIMENTAL NEUROLOGY (2015)
NLRP3 Inflammasome Is Expressed by Astrocytes in the SOD1 Mouse Model of ALS and in Human Sporadic ALS Patients
Sonja Johann et al.
GLIA (2015)
DNA Replication Dynamics of the GGGGCC Repeat of the C9orf72 Gene
Ryan Griffin Thys et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Aspirin Use Associated With Amyotrophic Lateral Sclerosis: a Total Population-Based Case-Control Study
Ching-Piao Tsai et al.
JOURNAL OF EPIDEMIOLOGY (2015)
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Roman Fischer et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Microglia Plasticity During Health one Disease: An Immunological Perspective
Anat Shemer et al.
TRENDS IN IMMUNOLOGY (2015)
Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS
Jacqueline C. Mitchell et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
The Role of Oxidative Stress in Neurodegenerative Diseases
Geon Ha Kim et al.
EXPERIMENTAL NEUROBIOLOGY (2015)
Targeting miR-155 Restores Abnormal Microglia and Attenuates Disease in SOD1 Mice
Oleg Butovsky et al.
ANNALS OF NEUROLOGY (2015)
Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis-A Pilot Study
Andre Maier et al.
PLOS ONE (2015)
Randomized phase 2 trial of NP001, a novel immune regulator
Robert G. Miller et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress
Yong-Jie Zhang et al.
ACTA NEUROPATHOLOGICA (2014)
Anti-inflammatory effects of Edaravone and Scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia
Yun Yuan et al.
BMC NEUROSCIENCE (2014)
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis
Paola Italiani et al.
JOURNAL OF NEUROINFLAMMATION (2014)
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
Ye Zhang et al.
JOURNAL OF NEUROSCIENCE (2014)
C9orf72 nucleotide repeat structures initiate molecular cascades of disease
Aaron R. Haeusler et al.
NATURE (2014)
Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models
Hyung-Jun Kim et al.
NATURE GENETICS (2014)
State of play in amyotrophic lateral sclerosis genetics
Alan E. Renton et al.
NATURE NEUROSCIENCE (2014)
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins
Sarah Mizielinska et al.
SCIENCE (2014)
Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells
Ilmin Kwon et al.
SCIENCE (2014)
The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis
Eveliina Pollari et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Blood-CNS barrier impairment in ALS patients versus an animal model
Svitlana Garbuzova-Davis et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis
Susan Byrne et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
NP001 regulation of macrophage activation markers in ALS: A phase I clinical and biomarker study
Robert G. Miller et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations
Ian R. Mackenzie et al.
ACTA NEUROPATHOLOGICA (2013)
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Kohji Mori et al.
SCIENCE (2013)
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features
Colin J. Mahoney et al.
BRAIN (2012)
Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS
Bing Liao et al.
EXPERIMENTAL NEUROLOGY (2012)
Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis
Jin Hee Shin et al.
JOURNAL OF NEUROCHEMISTRY (2012)
DNA secondary structures: stability and function of G-quadruplex structures
Matthew L. Bochman et al.
NATURE REVIEWS GENETICS (2012)
TREATMENT WITH EDARAVONE ATTENUATES ISCHEMIC BRAIN INJURY AND INHIBITS NEUROGENESIS IN THE SUBVENTRICULAR ZONE OF ADULT RATS AFTER FOCAL CEREBRAL ISCHEMIA AND REPERFUSION INJURY
P. Zhang et al.
NEUROSCIENCE (2012)
Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis
Johannes Brettschneider et al.
PLOS ONE (2012)
Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis
Philippe Corcia et al.
PLOS ONE (2012)
NADPH oxidases: novel therapeutic targets for neurodegenerative diseases
Hui-Ming Gao et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes
Pietro Fratta et al.
SCIENTIFIC REPORTS (2012)
Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72
Melissa E. Murray et al.
ACTA NEUROPATHOLOGICA (2011)
Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic Cooperation
Mireille Belanger et al.
CELL METABOLISM (2011)
The Role of Immune and Inflammatory Mechanisms in ALS
P. A. McCombe et al.
CURRENT MOLECULAR MEDICINE (2011)
Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice
A. Florence Keller et al.
EXPERIMENTAL NEUROLOGY (2011)
Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis
Felix Meissner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Nucleo-cytoplasmic shuttling of protein arginine methyltransferase 1 (PRMT1) requires enzymatic activity
Frank Herrmann et al.
GENES TO CELLS (2009)
TDP-43 is recruited to stress granules in conditions of oxidative insult
Claudia Colombrita et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation
Matthew J. Winton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study)
Hiide Yoshino et al.
AMYOTROPHIC LATERAL SCLEROSIS (2006)
Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis
David R. Beers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
Marc Cruts et al.
NATURE (2006)
Trial of celecoxib in amyotrophic lateral sclerosis
Merit E. Cudkowicz et al.
ANNALS OF NEUROLOGY (2006)
Audit of outcomes in motor neuron disease (MND) patients treated with riluzole
J. Douglas Mitchell et al.
AMYOTROPHIC LATERAL SCLEROSIS (2006)
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Piera Pasinelli et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism
WH Zhao et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Cyclooxygenase enzymes: Regulation and function
FA Fitzpatrick
CURRENT PHARMACEUTICAL DESIGN (2004)
A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis
PN Pompl et al.
FASEB JOURNAL (2003)
Cognitive impairment, frontotemporal dementia, and the motor neuron diseases
MJ Strong et al.
ANNALS OF NEUROLOGY (2003)
Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS
DB Drachman et al.
ANNALS OF NEUROLOGY (2002)
The overlap of amyotrophic lateral sclerosis and frontotemporal dementia
C Lomen-Hoerth et al.
NEUROLOGY (2002)
Minocycline slows disease progression in a mouse model of arnyotrophic lateral sclerosis
J Kriz et al.
NEUROBIOLOGY OF DISEASE (2002)
What is oxidative stress?
DJ Betteridge
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)